BFM
VTYX

Boothbay Fund Management’s Ventyx Biosciences VTYX Stock Holding History

Boothbay Fund Management’s Portfolio VTYX Stock Details VTYX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-251,994
Closed -$2.28M – 2509
2025
Q4 		$2.28M Sell
251,994
-180,533
-42% -$1.35M 0.03% 526
2025
Q3 		$1.35M Buy
432,527
+152,114
+54% +$403K 0.02% 717
2025
Q2 		$600K Sell
280,413
-72,452
-21% -$117K 0.01% 850
2025
Q1 		$406K Buy
352,865
+37,974
+12% +$65.2K 0.01% 941
2024
Q4 		$690K Buy
314,891
+259,863
+472% +$589K 0.02% 763
2024
Q3 		$120K Sell
55,028
-71,408
-56% -$164K ﹤0.01% 1438
2024
Q2 		$292K Sell
126,436
-18,566
-13% -$77.1K 0.01% 1167
2024
Q1 		$798K Buy
+145,002
New +$663K 0.02% 829
2023
Q2 		– Sell
-13,693
Closed -$472K – 2336
2023
Q1 		$459K Buy
+13,693
New +$532K 0.01% 1289

Other funds holding VTYX

IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

Boothbay Fund Management's VTYX Position: Q1 2026 in Review

Boothbay Fund Management sold out of Ventyx Biosciences (VTYX) in Q1 2026, closing a stake of 251,994 shares — an estimated $2.28M sold.

Boothbay Fund Management first reported a position in VTYX in Q1 2023 and held it in 9 quarters. The position peaked at $2.28M in Q4 2025. 1 fund tracked by Wall St. Rank holds VTYX as of Q1 2026.

  • Boothbay Fund Management reported no remaining Ventyx Biosciences position as of Q1 2026 after selling out during the quarter.
  • Boothbay Fund Management sold 251,994 Ventyx Biosciences shares in Q1 2026, an estimated $2.28M.
  • Boothbay Fund Management first reported a position in Ventyx Biosciences in Q1 2023 and held it in 9 quarters.
  • Boothbay Fund Management's Ventyx Biosciences position peaked at $2.28M in Q4 2025.
  • 1 fund tracked by Wall St. Rank held Ventyx Biosciences as of Q1 2026.

Based on Boothbay Fund Management's 13F filing for Q1 2026, filed 15 May 2026.